Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease [NA]
The TACAD program trial for Asian American family caregivers of people with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Effects of Personalized Music Listening in Advanced Alzheimer's [NA]
A completed clinical trial evaluating the effects of personalized music listening as an intervention in advanced Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease [Phase 3]
An update on a Phase 3 trial of Simufilam at 50 mg or 100 mg for Alzheimer's disease shows the study was terminated and results were posted …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Nasal Protollin in Early Symptomatic Alzheimer's Disease [Phase 1]
Phase 1 trial of nasal Protollin in early symptomatic Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease [Phase 2]
Phase 2 study of 50561 in mild to moderate Alzheimer's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes [NA]
Completed clinical trial evaluating in-home technology for caregivers of people with dementia and mild cognitive impairment in Spanish-langu…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2 [NA]
The clinical trial update notes that Aim 2 of a study on light therapy, metabolic syndrome, and Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease [Phase 1]
Phase 1 clinical trial evaluating transcranial magnetic stimulation combined with constraint-induced language therapy for Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: New Biomarker for Alzheimer's Disease Diagnostic [NA]
A completed clinical trial reports a new biomarker for diagnosing Alzheimer's disease and mild cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Light and the Effect on Metabolic Syndrome and Alzheimer's Disease [NA]
This is a completed clinical trial sponsored by Icahn School of Medicine at Mount Sinai. It studied the effect of light therapy on Alzheimer…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Correlation Between Knowledge, Attitude and Practices of Caregivers and Oral Health Status of Alzheimer's Disease Patients
This completed clinical trial investigates the relationship between caregivers' knowledge, attitudes, and practices and the oral health stat…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Musical Engagement of Brain LObes in Alzheimer's Disease Patients StudY [NA]
Clinical trial update reporting the completion and posted results of a study on musical engagement and brain activity in Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: MIND Diet in Relation to Malnutrition and Depression in AD
A completed clinical trial evaluating the MIND diet's impact on malnutrition and depression in Alzheimer's disease, including a healthy cont…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Anti-viral Therapy in Alzheimer's Disease [Phase 2]
A Phase 2 trial of an antiviral therapy in Alzheimer's disease with herpes simplex virus co-infection has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: [18F]APN-1607 PET in Subjects With AD Compared to HC [Phase 3]
A Phase 3 study evaluating the PET radiotracer [18F]APN-1607 in Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment [Phase 3]
This is a Phase 3 clinical trial update reporting safety and efficacy results for TRx0237 in Alzheimer's disease, including an open-label tr…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD) [Phase 2]
Phase 2 clinical trial evaluating subcutaneous GV1001 for mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation [NA]
A completed clinical trial evaluated the feasibility, safety, and tolerability of a virtual reality–based audiovisual stimulation approach i…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Care Ecosystem Consortium Effectiveness Study [NA]
The Care Ecosystem Consortium Effectiveness Study (NCT05669365) conducted by University of California, San Francisco has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated repurposing bromocriptine to influence beta-amyloid metabolism in Alzheimer's disease, including famili…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) [Phase 2]
Bepranemab (UCB0107) was studied in a Phase 2 trial for efficacy, safety, and tolerability in patients with mild cognitive impairment or mil…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002) [Phase 1]
Completion of a Phase 1 study evaluating MK-2214 in adults with mild cognitive impairment or mild-to-moderate Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: The Clinical Trial of Low Dose Irradiation for Alzheimer's Disease [Phase 2]
This entry indicates the completion of a Phase 2 clinical trial evaluating low-dose irradiation for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers [Phase 1]
Phase 1 study to assess safety and effects of single and multiple doses of KS101 in healthy volunteers; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Falls: A Marker of Preclinical AD
This clinical trial update reports the completion of a study evaluating falls as a potential marker of preclinical Alzheimer's disease.